nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—TPO—neck—skin cancer	0.0362	0.101	CbGeAlD
Dextrothyroxine—Infertility—Temozolomide—skin cancer	0.0254	0.0396	CcSEcCtD
Dextrothyroxine—SLCO4C1—nipple—skin cancer	0.0234	0.065	CbGeAlD
Dextrothyroxine—THRA—neck—skin cancer	0.0222	0.0617	CbGeAlD
Dextrothyroxine—THRB—neck—skin cancer	0.0222	0.0617	CbGeAlD
Dextrothyroxine—TPO—lymphoid tissue—skin cancer	0.019	0.0528	CbGeAlD
Dextrothyroxine—SLC7A5—nipple—skin cancer	0.0171	0.0476	CbGeAlD
Dextrothyroxine—THRA—connective tissue—skin cancer	0.0159	0.0442	CbGeAlD
Dextrothyroxine—SLCO4A1—nipple—skin cancer	0.0149	0.0415	CbGeAlD
Dextrothyroxine—Dehydration—Vismodegib—skin cancer	0.0141	0.0221	CcSEcCtD
Dextrothyroxine—SLCO4C1—mammalian vulva—skin cancer	0.0137	0.038	CbGeAlD
Dextrothyroxine—SLC7A5—connective tissue—skin cancer	0.0121	0.0337	CbGeAlD
Dextrothyroxine—Weight decreased—Vismodegib—skin cancer	0.0119	0.0186	CcSEcCtD
Dextrothyroxine—SLC7A5—epithelium—skin cancer	0.0115	0.032	CbGeAlD
Dextrothyroxine—THRB—female reproductive system—skin cancer	0.0112	0.0312	CbGeAlD
Dextrothyroxine—THRA—female reproductive system—skin cancer	0.0112	0.0312	CbGeAlD
Dextrothyroxine—SLC7A5—skin of body—skin cancer	0.011	0.0305	CbGeAlD
Dextrothyroxine—SLC7A5—mammalian vulva—skin cancer	0.00999	0.0278	CbGeAlD
Dextrothyroxine—THRA—head—skin cancer	0.00936	0.026	CbGeAlD
Dextrothyroxine—THRB—head—skin cancer	0.00936	0.026	CbGeAlD
Dextrothyroxine—Alopecia—Vismodegib—skin cancer	0.0093	0.0145	CcSEcCtD
Dextrothyroxine—SLC7A5—lymphoid tissue—skin cancer	0.00887	0.0247	CbGeAlD
Dextrothyroxine—SLCO4A1—mammalian vulva—skin cancer	0.00872	0.0243	CbGeAlD
Dextrothyroxine—SLC7A5—female reproductive system—skin cancer	0.00855	0.0238	CbGeAlD
Dextrothyroxine—Cardiac failure—Imiquimod—skin cancer	0.00821	0.0128	CcSEcCtD
Dextrothyroxine—Menstruation irregular—Docetaxel—skin cancer	0.00795	0.0124	CcSEcCtD
Dextrothyroxine—Arthralgia—Vismodegib—skin cancer	0.0078	0.0122	CcSEcCtD
Dextrothyroxine—SLCO1C1—head—skin cancer	0.00779	0.0217	CbGeAlD
Dextrothyroxine—Irritability—Imiquimod—skin cancer	0.00765	0.0119	CcSEcCtD
Dextrothyroxine—Wheezing—Bleomycin—skin cancer	0.00762	0.0119	CcSEcCtD
Dextrothyroxine—SLCO4A1—female reproductive system—skin cancer	0.00747	0.0208	CbGeAlD
Dextrothyroxine—Weight decreased—Vemurafenib—skin cancer	0.00735	0.0115	CcSEcCtD
Dextrothyroxine—SLC7A5—head—skin cancer	0.00715	0.0199	CbGeAlD
Dextrothyroxine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00681	0.0106	CcSEcCtD
Dextrothyroxine—Sweating increased—Imiquimod—skin cancer	0.00675	0.0105	CcSEcCtD
Dextrothyroxine—SLCO1B1—female reproductive system—skin cancer	0.00657	0.0183	CbGeAlD
Dextrothyroxine—THRA—lymph node—skin cancer	0.00656	0.0182	CbGeAlD
Dextrothyroxine—THRB—lymph node—skin cancer	0.00656	0.0182	CbGeAlD
Dextrothyroxine—Fatigue—Vismodegib—skin cancer	0.00645	0.0101	CcSEcCtD
Dextrothyroxine—Disorientation—Bleomycin—skin cancer	0.00637	0.00994	CcSEcCtD
Dextrothyroxine—SLCO4A1—head—skin cancer	0.00624	0.0174	CbGeAlD
Dextrothyroxine—Gastrointestinal pain—Vismodegib—skin cancer	0.00611	0.00955	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Imiquimod—skin cancer	0.00609	0.00951	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Imiquimod—skin cancer	0.00606	0.00945	CcSEcCtD
Dextrothyroxine—Abdominal pain—Vismodegib—skin cancer	0.00591	0.00923	CcSEcCtD
Dextrothyroxine—Alopecia—Vemurafenib—skin cancer	0.00575	0.00897	CcSEcCtD
Dextrothyroxine—Coma—Fluorouracil—skin cancer	0.00557	0.0087	CcSEcCtD
Dextrothyroxine—SLCO1C1—lymph node—skin cancer	0.00545	0.0152	CbGeAlD
Dextrothyroxine—Asthenia—Vismodegib—skin cancer	0.00537	0.00838	CcSEcCtD
Dextrothyroxine—Pruritus—Vismodegib—skin cancer	0.00529	0.00826	CcSEcCtD
Dextrothyroxine—Flushing—Imiquimod—skin cancer	0.00515	0.00804	CcSEcCtD
Dextrothyroxine—Diarrhoea—Vismodegib—skin cancer	0.00512	0.00799	CcSEcCtD
Dextrothyroxine—SLC7A5—lymph node—skin cancer	0.005	0.0139	CbGeAlD
Dextrothyroxine—Arrhythmia—Imiquimod—skin cancer	0.00495	0.00774	CcSEcCtD
Dextrothyroxine—Disorientation—Fluorouracil—skin cancer	0.00495	0.00773	CcSEcCtD
Dextrothyroxine—Alopecia—Imiquimod—skin cancer	0.0049	0.00765	CcSEcCtD
Dextrothyroxine—Arthralgia—Vemurafenib—skin cancer	0.00482	0.00752	CcSEcCtD
Dextrothyroxine—Vomiting—Vismodegib—skin cancer	0.00475	0.00742	CcSEcCtD
Dextrothyroxine—Affect lability—Temozolomide—skin cancer	0.00473	0.00738	CcSEcCtD
Dextrothyroxine—Rash—Vismodegib—skin cancer	0.00471	0.00736	CcSEcCtD
Dextrothyroxine—Dermatitis—Vismodegib—skin cancer	0.00471	0.00735	CcSEcCtD
Dextrothyroxine—Dysphagia—Dactinomycin—skin cancer	0.00459	0.00717	CcSEcCtD
Dextrothyroxine—Mood swings—Temozolomide—skin cancer	0.00455	0.00711	CcSEcCtD
Dextrothyroxine—Cardiac failure—Fluorouracil—skin cancer	0.00454	0.00708	CcSEcCtD
Dextrothyroxine—Dehydration—Temozolomide—skin cancer	0.00447	0.00698	CcSEcCtD
Dextrothyroxine—Weight decreased—Bleomycin—skin cancer	0.00445	0.00695	CcSEcCtD
Dextrothyroxine—Nausea—Vismodegib—skin cancer	0.00444	0.00694	CcSEcCtD
Dextrothyroxine—Agitation—Imiquimod—skin cancer	0.00444	0.00693	CcSEcCtD
Dextrothyroxine—Angioedema—Imiquimod—skin cancer	0.00441	0.00689	CcSEcCtD
Dextrothyroxine—SLCO4A1—lymph node—skin cancer	0.00437	0.0122	CbGeAlD
Dextrothyroxine—Acute coronary syndrome—Bleomycin—skin cancer	0.00433	0.00675	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Bleomycin—skin cancer	0.0043	0.00672	CcSEcCtD
Dextrothyroxine—Palpitations—Imiquimod—skin cancer	0.00427	0.00666	CcSEcCtD
Dextrothyroxine—Muscular weakness—Temozolomide—skin cancer	0.00424	0.00662	CcSEcCtD
Dextrothyroxine—Irritability—Fluorouracil—skin cancer	0.00422	0.0066	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00421	0.00657	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Fluorouracil—skin cancer	0.00421	0.00657	CcSEcCtD
Dextrothyroxine—Convulsion—Imiquimod—skin cancer	0.00418	0.00653	CcSEcCtD
Dextrothyroxine—Dysphagia—Temozolomide—skin cancer	0.00415	0.00648	CcSEcCtD
Dextrothyroxine—Arthralgia—Imiquimod—skin cancer	0.00411	0.00642	CcSEcCtD
Dextrothyroxine—Anxiety—Imiquimod—skin cancer	0.0041	0.00639	CcSEcCtD
Dextrothyroxine—Sweating increased—Temozolomide—skin cancer	0.00404	0.00631	CcSEcCtD
Dextrothyroxine—Fatigue—Vemurafenib—skin cancer	0.00398	0.00622	CcSEcCtD
Dextrothyroxine—Muscular weakness—Fluorouracil—skin cancer	0.0039	0.0061	CcSEcCtD
Dextrothyroxine—Shock—Imiquimod—skin cancer	0.00388	0.00605	CcSEcCtD
Dextrothyroxine—Tachycardia—Imiquimod—skin cancer	0.00385	0.006	CcSEcCtD
Dextrothyroxine—Dysphagia—Fluorouracil—skin cancer	0.00383	0.00597	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Imiquimod—skin cancer	0.00381	0.00595	CcSEcCtD
Dextrothyroxine—Weight decreased—Temozolomide—skin cancer	0.00376	0.00586	CcSEcCtD
Dextrothyroxine—Angina pectoris—Fluorouracil—skin cancer	0.00373	0.00582	CcSEcCtD
Dextrothyroxine—Flushing—Bleomycin—skin cancer	0.00366	0.00571	CcSEcCtD
Dextrothyroxine—Body temperature increased—Vemurafenib—skin cancer	0.00365	0.0057	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00359	0.0056	CcSEcCtD
Dextrothyroxine—Insomnia—Imiquimod—skin cancer	0.00356	0.00556	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Docetaxel—skin cancer	0.00352	0.0055	CcSEcCtD
Dextrothyroxine—Dyspnoea—Imiquimod—skin cancer	0.00351	0.00548	CcSEcCtD
Dextrothyroxine—Alopecia—Bleomycin—skin cancer	0.00348	0.00544	CcSEcCtD
Dextrothyroxine—Flushing—Dactinomycin—skin cancer	0.00341	0.00532	CcSEcCtD
Dextrothyroxine—Fatigue—Imiquimod—skin cancer	0.0034	0.0053	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Fluorouracil—skin cancer	0.00336	0.00525	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Fluorouracil—skin cancer	0.00334	0.00522	CcSEcCtD
Dextrothyroxine—Asthenia—Vemurafenib—skin cancer	0.00331	0.00518	CcSEcCtD
Dextrothyroxine—Cardiac failure—Docetaxel—skin cancer	0.00327	0.00511	CcSEcCtD
Dextrothyroxine—Pruritus—Vemurafenib—skin cancer	0.00327	0.0051	CcSEcCtD
Dextrothyroxine—Alopecia—Dactinomycin—skin cancer	0.00325	0.00507	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Imiquimod—skin cancer	0.00325	0.00507	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Imiquimod—skin cancer	0.00322	0.00503	CcSEcCtD
Dextrothyroxine—Diarrhoea—Vemurafenib—skin cancer	0.00316	0.00494	CcSEcCtD
Dextrothyroxine—Urticaria—Imiquimod—skin cancer	0.00313	0.00489	CcSEcCtD
Dextrothyroxine—Abdominal pain—Imiquimod—skin cancer	0.00311	0.00486	CcSEcCtD
Dextrothyroxine—Body temperature increased—Imiquimod—skin cancer	0.00311	0.00486	CcSEcCtD
Dextrothyroxine—Flushing—Temozolomide—skin cancer	0.00308	0.00482	CcSEcCtD
Dextrothyroxine—Dehydration—Docetaxel—skin cancer	0.00297	0.00464	CcSEcCtD
Dextrothyroxine—Vomiting—Vemurafenib—skin cancer	0.00294	0.00459	CcSEcCtD
Dextrothyroxine—Alopecia—Temozolomide—skin cancer	0.00294	0.00459	CcSEcCtD
Dextrothyroxine—Rash—Vemurafenib—skin cancer	0.00291	0.00455	CcSEcCtD
Dextrothyroxine—Dermatitis—Vemurafenib—skin cancer	0.00291	0.00454	CcSEcCtD
Dextrothyroxine—Headache—Vemurafenib—skin cancer	0.00289	0.00452	CcSEcCtD
Dextrothyroxine—Asthenia—Imiquimod—skin cancer	0.00283	0.00441	CcSEcCtD
Dextrothyroxine—Confusional state—Bleomycin—skin cancer	0.00282	0.00441	CcSEcCtD
Dextrothyroxine—Pruritus—Imiquimod—skin cancer	0.00279	0.00435	CcSEcCtD
Dextrothyroxine—Dysphagia—Docetaxel—skin cancer	0.00276	0.00431	CcSEcCtD
Dextrothyroxine—Nausea—Vemurafenib—skin cancer	0.00274	0.00428	CcSEcCtD
Dextrothyroxine—Arrhythmia—Fluorouracil—skin cancer	0.00274	0.00427	CcSEcCtD
Dextrothyroxine—Tremor—Temozolomide—skin cancer	0.00271	0.00423	CcSEcCtD
Dextrothyroxine—Alopecia—Fluorouracil—skin cancer	0.00271	0.00422	CcSEcCtD
Dextrothyroxine—Diarrhoea—Imiquimod—skin cancer	0.0027	0.00421	CcSEcCtD
Dextrothyroxine—Angina pectoris—Docetaxel—skin cancer	0.00269	0.0042	CcSEcCtD
Dextrothyroxine—Agitation—Temozolomide—skin cancer	0.00266	0.00415	CcSEcCtD
Dextrothyroxine—Angioedema—Temozolomide—skin cancer	0.00264	0.00413	CcSEcCtD
Dextrothyroxine—Palpitations—Temozolomide—skin cancer	0.00256	0.00399	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00255	0.00398	CcSEcCtD
Dextrothyroxine—Convulsion—Temozolomide—skin cancer	0.00251	0.00391	CcSEcCtD
Dextrothyroxine—Vomiting—Imiquimod—skin cancer	0.0025	0.00391	CcSEcCtD
Dextrothyroxine—Weight decreased—Docetaxel—skin cancer	0.0025	0.0039	CcSEcCtD
Dextrothyroxine—Dyspnoea—Bleomycin—skin cancer	0.0025	0.0039	CcSEcCtD
Dextrothyroxine—Rash—Imiquimod—skin cancer	0.00248	0.00388	CcSEcCtD
Dextrothyroxine—Dermatitis—Imiquimod—skin cancer	0.00248	0.00388	CcSEcCtD
Dextrothyroxine—Headache—Imiquimod—skin cancer	0.00247	0.00385	CcSEcCtD
Dextrothyroxine—Arthralgia—Temozolomide—skin cancer	0.00246	0.00385	CcSEcCtD
Dextrothyroxine—Anxiety—Temozolomide—skin cancer	0.00245	0.00383	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Docetaxel—skin cancer	0.00243	0.00379	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Docetaxel—skin cancer	0.00241	0.00377	CcSEcCtD
Dextrothyroxine—Confusional state—Temozolomide—skin cancer	0.00238	0.00372	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00238	0.00371	CcSEcCtD
Dextrothyroxine—Nausea—Imiquimod—skin cancer	0.00234	0.00365	CcSEcCtD
Dextrothyroxine—Convulsion—Fluorouracil—skin cancer	0.00231	0.00361	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Bleomycin—skin cancer	0.00231	0.0036	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Temozolomide—skin cancer	0.00228	0.00356	CcSEcCtD
Dextrothyroxine—Fatigue—Dactinomycin—skin cancer	0.00225	0.00351	CcSEcCtD
Dextrothyroxine—Urticaria—Bleomycin—skin cancer	0.00222	0.00347	CcSEcCtD
Dextrothyroxine—Body temperature increased—Bleomycin—skin cancer	0.00221	0.00345	CcSEcCtD
Dextrothyroxine—Confusional state—Fluorouracil—skin cancer	0.00219	0.00342	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Dactinomycin—skin cancer	0.00215	0.00336	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00215	0.00336	CcSEcCtD
Dextrothyroxine—Insomnia—Temozolomide—skin cancer	0.00214	0.00333	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00213	0.00333	CcSEcCtD
Dextrothyroxine—Tachycardia—Fluorouracil—skin cancer	0.00212	0.00332	CcSEcCtD
Dextrothyroxine—Dyspnoea—Temozolomide—skin cancer	0.0021	0.00329	CcSEcCtD
Dextrothyroxine—Body temperature increased—Dactinomycin—skin cancer	0.00206	0.00322	CcSEcCtD
Dextrothyroxine—Abdominal pain—Dactinomycin—skin cancer	0.00206	0.00322	CcSEcCtD
Dextrothyroxine—Flushing—Docetaxel—skin cancer	0.00205	0.0032	CcSEcCtD
Dextrothyroxine—Fatigue—Temozolomide—skin cancer	0.00204	0.00318	CcSEcCtD
Dextrothyroxine—Asthenia—Bleomycin—skin cancer	0.00201	0.00314	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00198	0.00309	CcSEcCtD
Dextrothyroxine—Pruritus—Bleomycin—skin cancer	0.00198	0.00309	CcSEcCtD
Dextrothyroxine—Arrhythmia—Docetaxel—skin cancer	0.00197	0.00308	CcSEcCtD
Dextrothyroxine—Insomnia—Fluorouracil—skin cancer	0.00197	0.00307	CcSEcCtD
Dextrothyroxine—Alopecia—Docetaxel—skin cancer	0.00195	0.00305	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Temozolomide—skin cancer	0.00195	0.00304	CcSEcCtD
Dextrothyroxine—Dyspnoea—Fluorouracil—skin cancer	0.00194	0.00303	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Temozolomide—skin cancer	0.00193	0.00301	CcSEcCtD
Dextrothyroxine—Urticaria—Temozolomide—skin cancer	0.00188	0.00293	CcSEcCtD
Dextrothyroxine—Asthenia—Dactinomycin—skin cancer	0.00187	0.00292	CcSEcCtD
Dextrothyroxine—Body temperature increased—Temozolomide—skin cancer	0.00187	0.00291	CcSEcCtD
Dextrothyroxine—Abdominal pain—Temozolomide—skin cancer	0.00187	0.00291	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Fluorouracil—skin cancer	0.00179	0.0028	CcSEcCtD
Dextrothyroxine—Diarrhoea—Dactinomycin—skin cancer	0.00179	0.00279	CcSEcCtD
Dextrothyroxine—Vomiting—Bleomycin—skin cancer	0.00178	0.00278	CcSEcCtD
Dextrothyroxine—Rash—Bleomycin—skin cancer	0.00176	0.00276	CcSEcCtD
Dextrothyroxine—Dermatitis—Bleomycin—skin cancer	0.00176	0.00275	CcSEcCtD
Dextrothyroxine—Urticaria—Fluorouracil—skin cancer	0.00173	0.0027	CcSEcCtD
Dextrothyroxine—Body temperature increased—Fluorouracil—skin cancer	0.00172	0.00269	CcSEcCtD
Dextrothyroxine—Palpitations—Docetaxel—skin cancer	0.0017	0.00265	CcSEcCtD
Dextrothyroxine—Asthenia—Temozolomide—skin cancer	0.00169	0.00264	CcSEcCtD
Dextrothyroxine—Pruritus—Temozolomide—skin cancer	0.00167	0.00261	CcSEcCtD
Dextrothyroxine—Convulsion—Docetaxel—skin cancer	0.00167	0.0026	CcSEcCtD
Dextrothyroxine—Nausea—Bleomycin—skin cancer	0.00166	0.0026	CcSEcCtD
Dextrothyroxine—Vomiting—Dactinomycin—skin cancer	0.00166	0.00259	CcSEcCtD
Dextrothyroxine—Rash—Dactinomycin—skin cancer	0.00165	0.00257	CcSEcCtD
Dextrothyroxine—Arthralgia—Docetaxel—skin cancer	0.00164	0.00256	CcSEcCtD
Dextrothyroxine—Diarrhoea—Temozolomide—skin cancer	0.00162	0.00252	CcSEcCtD
Dextrothyroxine—Confusional state—Docetaxel—skin cancer	0.00158	0.00247	CcSEcCtD
Dextrothyroxine—Nausea—Dactinomycin—skin cancer	0.00155	0.00242	CcSEcCtD
Dextrothyroxine—Shock—Docetaxel—skin cancer	0.00154	0.00241	CcSEcCtD
Dextrothyroxine—Pruritus—Fluorouracil—skin cancer	0.00154	0.0024	CcSEcCtD
Dextrothyroxine—Tachycardia—Docetaxel—skin cancer	0.00153	0.00239	CcSEcCtD
Dextrothyroxine—Vomiting—Temozolomide—skin cancer	0.0015	0.00234	CcSEcCtD
Dextrothyroxine—Rash—Temozolomide—skin cancer	0.00149	0.00232	CcSEcCtD
Dextrothyroxine—Diarrhoea—Fluorouracil—skin cancer	0.00149	0.00232	CcSEcCtD
Dextrothyroxine—Dermatitis—Temozolomide—skin cancer	0.00149	0.00232	CcSEcCtD
Dextrothyroxine—Headache—Temozolomide—skin cancer	0.00148	0.00231	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00143	0.00223	CcSEcCtD
Dextrothyroxine—Insomnia—Docetaxel—skin cancer	0.00142	0.00222	CcSEcCtD
Dextrothyroxine—Nausea—Temozolomide—skin cancer	0.0014	0.00219	CcSEcCtD
Dextrothyroxine—Dyspnoea—Docetaxel—skin cancer	0.0014	0.00219	CcSEcCtD
Dextrothyroxine—Vomiting—Fluorouracil—skin cancer	0.00138	0.00216	CcSEcCtD
Dextrothyroxine—Rash—Fluorouracil—skin cancer	0.00137	0.00214	CcSEcCtD
Dextrothyroxine—Dermatitis—Fluorouracil—skin cancer	0.00137	0.00214	CcSEcCtD
Dextrothyroxine—Headache—Fluorouracil—skin cancer	0.00136	0.00213	CcSEcCtD
Dextrothyroxine—Fatigue—Docetaxel—skin cancer	0.00135	0.00211	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Docetaxel—skin cancer	0.00129	0.00202	CcSEcCtD
Dextrothyroxine—Nausea—Fluorouracil—skin cancer	0.00129	0.00202	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Docetaxel—skin cancer	0.00128	0.002	CcSEcCtD
Dextrothyroxine—Abdominal pain—Docetaxel—skin cancer	0.00124	0.00194	CcSEcCtD
Dextrothyroxine—Body temperature increased—Docetaxel—skin cancer	0.00124	0.00194	CcSEcCtD
Dextrothyroxine—Asthenia—Docetaxel—skin cancer	0.00113	0.00176	CcSEcCtD
Dextrothyroxine—Pruritus—Docetaxel—skin cancer	0.00111	0.00173	CcSEcCtD
Dextrothyroxine—Diarrhoea—Docetaxel—skin cancer	0.00107	0.00168	CcSEcCtD
Dextrothyroxine—Vomiting—Docetaxel—skin cancer	0.000998	0.00156	CcSEcCtD
Dextrothyroxine—Rash—Docetaxel—skin cancer	0.00099	0.00155	CcSEcCtD
Dextrothyroxine—Dermatitis—Docetaxel—skin cancer	0.000989	0.00154	CcSEcCtD
Dextrothyroxine—Headache—Docetaxel—skin cancer	0.000984	0.00154	CcSEcCtD
Dextrothyroxine—Nausea—Docetaxel—skin cancer	0.000933	0.00146	CcSEcCtD
